Home Stocks AZTR Azitra Inc (NYSE American: AZTR) Healthcare · Biotechnology
$0.61
Last close · Nov 17, 2026 · NYSE American USD
The Quantellect read. Short interest is 5.97% of float with a 95.14% borrow fee. Zero active firms cover the stock as of Nov 18, 2026; zero active firms with targets average $6.50 over 12 months. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Mixed valuation signals P/S 240.0× vs peer median 13.9×
Momentum Neutral RSI (14) 51.2 (overbought above 70, oversold below 30) · as of Nov 17, 2026
Trend Below both averages $0.61 vs $1.31 and $1.78 · as of Nov 17, 2026
Short interest 6.0% of float FINRA settlement Oct 30, 2026
SMA 10 $0.66 SMA 20 $0.83 SMA 50 $1.31 SMA 200 $1.78
Nov 17, 2026 O $0.63 H $0.63 L $0.58 C $0.61 Vol 32K
×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date May 18, 2026 ET Last date Nov 17, 2026 ET Open $1.86 High $3.30 Low $0.52 Close $0.61 Volume 965,750,794 Plotted bars 120
Plotted OHLCV bars May 18, 2026 ET · Open $1.86 · High $1.90 · Low $1.81 · Close $1.90 · Volume 626,779 May 19, 2026 ET · Open $1.91 · High $1.94 · Low $1.84 · Close $1.90 · Volume 403,958 May 20, 2026 ET · Open $1.90 · High $2.02 · Low $1.85 · Close $1.97 · Volume 751,973 May 21, 2026 ET · Open $1.95 · High $2.17 · Low $1.95 · Close $2.12 · Volume 693,736 May 22, 2026 ET · Open $2.12 · High $2.18 · Low $2.00 · Close $2.04 · Volume 546,217 May 26, 2026 ET · Open $2.02 · High $2.10 · Low $1.97 · Close $2.10 · Volume 322,898 May 27, 2026 ET · Open $2.08 · High $2.09 · Low $2.02 · Close $2.07 · Volume 539,862 May 28, 2026 ET · Open $2.05 · High $2.15 · Low $2.03 · Close $2.05 · Volume 410,205 May 29, 2026 ET · Open $2.13 · High $2.35 · Low $2.06 · Close $2.30 · Volume 1,370,543 Jun 1, 2026 ET · Open $2.29 · High $2.35 · Low $2.16 · Close $2.24 · Volume 419,209 Jun 2, 2026 ET · Open $2.26 · High $2.26 · Low $2.11 · Close $2.16 · Volume 279,887 Jun 3, 2026 ET · Open $2.20 · High $2.30 · Low $2.12 · Close $2.24 · Volume 269,883 Jun 4, 2026 ET · Open $2.22 · High $2.27 · Low $2.15 · Close $2.18 · Volume 204,881 Jun 5, 2026 ET · Open $2.15 · High $2.20 · Low $2.10 · Close $2.11 · Volume 127,834 Jun 8, 2026 ET · Open $2.00 · High $2.10 · Low $1.90 · Close $2.04 · Volume 357,607 Jun 9, 2026 ET · Open $2.00 · High $2.15 · Low $2.00 · Close $2.12 · Volume 365,226 Jun 10, 2026 ET · Open $2.11 · High $2.38 · Low $2.11 · Close $2.38 · Volume 505,694 Jun 11, 2026 ET · Open $2.29 · High $2.29 · Low $2.09 · Close $2.21 · Volume 192,556 Jun 12, 2026 ET · Open $2.16 · High $2.21 · Low $2.12 · Close $2.12 · Volume 212,861 Jun 15, 2026 ET · Open $2.12 · High $2.22 · Low $1.97 · Close $1.98 · Volume 734,772 Jun 16, 2026 ET · Open $2.05 · High $2.05 · Low $1.78 · Close $1.84 · Volume 850,890 Jun 17, 2026 ET · Open $3.20 · High $3.30 · Low $1.85 · Close $2.03 · Volume 381,958,312 Jun 18, 2026 ET · Open $2.17 · High $2.48 · Low $1.72 · Close $1.72 · Volume 120,220,360 Jun 22, 2026 ET · Open $2.30 · High $2.57 · Low $2.03 · Close $2.30 · Volume 143,301,142 Jun 23, 2026 ET · Open $2.05 · High $2.15 · Low $2.01 · Close $2.10 · Volume 11,281,244 Jun 24, 2026 ET · Open $2.00 · High $2.12 · Low $1.86 · Close $2.10 · Volume 5,409,938 Jun 25, 2026 ET · Open $1.83 · High $1.87 · Low $1.64 · Close $1.66 · Volume 5,750,925 Jun 26, 2026 ET · Open $1.60 · High $1.70 · Low $1.53 · Close $1.67 · Volume 2,589,026 Jun 29, 2026 ET · Open $1.70 · High $1.77 · Low $1.62 · Close $1.77 · Volume 4,610,431 Jun 30, 2026 ET · Open $1.71 · High $1.71 · Low $1.62 · Close $1.68 · Volume 1,756,389 Jul 1, 2026 ET · Open $1.58 · High $1.70 · Low $1.57 · Close $1.67 · Volume 1,374,267 Jul 2, 2026 ET · Open $1.61 · High $1.66 · Low $1.51 · Close $1.51 · Volume 1,869,072 Jul 6, 2026 ET · Open $1.50 · High $1.54 · Low $1.44 · Close $1.49 · Volume 1,678,526 Jul 7, 2026 ET · Open $1.49 · High $1.57 · Low $1.48 · Close $1.51 · Volume 1,196,526 Jul 8, 2026 ET · Open $1.46 · High $1.54 · Low $1.43 · Close $1.51 · Volume 1,197,995 Jul 9, 2026 ET · Open $1.48 · High $1.53 · Low $1.46 · Close $1.49 · Volume 1,337,384 Jul 10, 2026 ET · Open $1.48 · High $1.49 · Low $1.42 · Close $1.42 · Volume 1,147,215 Jul 13, 2026 ET · Open $1.40 · High $1.42 · Low $1.30 · Close $1.30 · Volume 1,922,995 Jul 14, 2026 ET · Open $1.20 · High $1.30 · Low $1.20 · Close $1.29 · Volume 927,416 Jul 15, 2026 ET · Open $1.30 · High $1.44 · Low $1.26 · Close $1.35 · Volume 6,947,778 Jul 16, 2026 ET · Open $1.34 · High $1.34 · Low $1.29 · Close $1.33 · Volume 1,082,826 Jul 17, 2026 ET · Open $1.30 · High $1.45 · Low $1.29 · Close $1.39 · Volume 1,730,303 Jul 20, 2026 ET · Open $1.39 · High $1.51 · Low $1.38 · Close $1.46 · Volume 2,075,608 Jul 21, 2026 ET · Open $1.43 · High $1.43 · Low $1.34 · Close $1.36 · Volume 454,414 Jul 22, 2026 ET · Open $1.33 · High $1.35 · Low $1.27 · Close $1.30 · Volume 422,473 Jul 23, 2026 ET · Open $1.30 · High $1.32 · Low $1.25 · Close $1.27 · Volume 480,086 Jul 24, 2026 ET · Open $1.30 · High $1.30 · Low $1.26 · Close $1.26 · Volume 357,577 Jul 27, 2026 ET · Open $1.26 · High $1.33 · Low $1.26 · Close $1.28 · Volume 406,853 Jul 28, 2026 ET · Open $1.30 · High $1.35 · Low $1.28 · Close $1.30 · Volume 331,203 Jul 29, 2026 ET · Open $1.31 · High $1.35 · Low $1.27 · Close $1.28 · Volume 533,539 Jul 30, 2026 ET · Open $1.30 · High $1.34 · Low $1.29 · Close $1.31 · Volume 414,212 Jul 31, 2026 ET · Open $1.35 · High $1.36 · Low $1.31 · Close $1.33 · Volume 944,448 Aug 3, 2026 ET · Open $1.34 · High $1.47 · Low $1.28 · Close $1.33 · Volume 14,100,162 Aug 4, 2026 ET · Open $1.33 · High $1.40 · Low $1.32 · Close $1.38 · Volume 502,971 Aug 5, 2026 ET · Open $1.40 · High $1.40 · Low $1.34 · Close $1.39 · Volume 606,709 Aug 6, 2026 ET · Open $1.35 · High $1.40 · Low $1.31 · Close $1.35 · Volume 228,559 Aug 7, 2026 ET · Open $1.32 · High $1.38 · Low $1.32 · Close $1.35 · Volume 411,415 Aug 10, 2026 ET · Open $1.31 · High $1.43 · Low $1.31 · Close $1.40 · Volume 995,912 Aug 11, 2026 ET · Open $1.40 · High $1.50 · Low $1.32 · Close $1.43 · Volume 2,095,009 Aug 12, 2026 ET · Open $1.39 · High $1.39 · Low $1.33 · Close $1.35 · Volume 1,311,543 Aug 13, 2026 ET · Open $1.32 · High $1.41 · Low $1.29 · Close $1.40 · Volume 1,132,178 Aug 14, 2026 ET · Open $1.46 · High $1.46 · Low $1.36 · Close $1.39 · Volume 1,044,125 Aug 17, 2026 ET · Open $1.37 · High $1.38 · Low $1.35 · Close $1.35 · Volume 478,873 Aug 18, 2026 ET · Open $1.35 · High $1.35 · Low $1.25 · Close $1.25 · Volume 1,115,050 Aug 19, 2026 ET · Open $1.27 · High $1.29 · Low $1.23 · Close $1.25 · Volume 602,349 Aug 20, 2026 ET · Open $1.30 · High $1.30 · Low $1.26 · Close $1.27 · Volume 478,366 Aug 21, 2026 ET · Open $1.35 · High $1.41 · Low $1.30 · Close $1.33 · Volume 2,000,290 Aug 24, 2026 ET · Open $1.32 · High $1.60 · Low $1.28 · Close $1.50 · Volume 27,725,383 Aug 25, 2026 ET · Open $1.59 · High $1.65 · Low $1.47 · Close $1.58 · Volume 4,915,587 Aug 26, 2026 ET · Open $1.57 · High $1.84 · Low $1.53 · Close $1.73 · Volume 5,108,334 Aug 27, 2026 ET · Open $1.74 · High $1.89 · Low $1.65 · Close $1.86 · Volume 2,433,712 Aug 28, 2026 ET · Open $1.82 · High $1.89 · Low $1.71 · Close $1.77 · Volume 1,031,858 Aug 31, 2026 ET · Open $1.73 · High $1.77 · Low $1.69 · Close $1.75 · Volume 645,515 Sep 1, 2026 ET · Open $1.73 · High $1.78 · Low $1.71 · Close $1.77 · Volume 373,817 Sep 2, 2026 ET · Open $1.71 · High $1.83 · Low $1.69 · Close $1.81 · Volume 531,181 Sep 3, 2026 ET · Open $1.76 · High $1.82 · Low $1.75 · Close $1.80 · Volume 309,560 Sep 4, 2026 ET · Open $1.78 · High $1.80 · Low $1.70 · Close $1.80 · Volume 340,016 Sep 8, 2026 ET · Open $1.75 · High $1.79 · Low $1.72 · Close $1.72 · Volume 294,475 Sep 9, 2026 ET · Open $1.71 · High $1.83 · Low $1.69 · Close $1.78 · Volume 607,234 Sep 10, 2026 ET · Open $1.78 · High $1.88 · Low $1.73 · Close $1.80 · Volume 570,110 Sep 11, 2026 ET · Open $1.82 · High $1.85 · Low $1.77 · Close $1.78 · Volume 300,403 Sep 14, 2026 ET · Open $1.85 · High $1.91 · Low $1.76 · Close $1.76 · Volume 1,302,000 Sep 15, 2026 ET · Open $1.78 · High $1.79 · Low $1.71 · Close $1.71 · Volume 476,266 Sep 16, 2026 ET · Open $1.76 · High $1.76 · Low $1.61 · Close $1.62 · Volume 1,124,436 Sep 17, 2026 ET · Open $1.62 · High $1.80 · Low $1.62 · Close $1.78 · Volume 568,473 Sep 18, 2026 ET · Open $1.81 · High $1.81 · Low $1.70 · Close $1.74 · Volume 1,120,092 Sep 21, 2026 ET · Open $1.77 · High $1.77 · Low $1.67 · Close $1.71 · Volume 620,044 Sep 22, 2026 ET · Open $1.72 · High $1.74 · Low $1.66 · Close $1.71 · Volume 296,467 Sep 23, 2026 ET · Open $1.70 · High $1.75 · Low $1.65 · Close $1.66 · Volume 849,458 Sep 24, 2026 ET · Open $1.66 · High $1.68 · Low $1.59 · Close $1.67 · Volume 605,972 Sep 25, 2026 ET · Open $1.61 · High $1.69 · Low $1.61 · Close $1.68 · Volume 159,308 Sep 28, 2026 ET · Open $1.70 · High $1.75 · Low $1.63 · Close $1.70 · Volume 617,078 Sep 29, 2026 ET · Open $1.64 · High $1.67 · Low $1.24 · Close $1.31 · Volume 3,214,474 Sep 30, 2026 ET · Open $1.34 · High $1.39 · Low $1.32 · Close $1.38 · Volume 611,017 Oct 1, 2026 ET · Open $1.39 · High $1.47 · Low $1.23 · Close $1.29 · Volume 1,429,203 Oct 2, 2026 ET · Open $1.34 · High $1.38 · Low $1.30 · Close $1.32 · Volume 825,843 Oct 5, 2026 ET · Open $1.38 · High $1.40 · Low $1.30 · Close $1.37 · Volume 622,884 Oct 6, 2026 ET · Open $1.40 · High $1.40 · Low $1.30 · Close $1.30 · Volume 413,227 Oct 7, 2026 ET · Open $1.33 · High $1.37 · Low $1.30 · Close $1.32 · Volume 290,369 Oct 8, 2026 ET · Open $1.33 · High $1.35 · Low $1.30 · Close $1.32 · Volume 287,142 Oct 9, 2026 ET · Open $1.30 · High $1.32 · Low $1.26 · Close $1.30 · Volume 323,000 Oct 12, 2026 ET · Open $1.30 · High $1.32 · Low $1.16 · Close $1.18 · Volume 476,782 Oct 13, 2026 ET · Open $1.21 · High $1.21 · Low $0.52 · Close $0.72 · Volume 2,670,553 Oct 26, 2026 ET · Open $1.04 · High $2.13 · Low $0.91 · Close $1.53 · Volume 143,971,032 Oct 27, 2026 ET · Open $1.21 · High $1.32 · Low $1.05 · Close $1.12 · Volume 7,835,148 Oct 28, 2026 ET · Open $1.09 · High $1.11 · Low $0.86 · Close $0.90 · Volume 2,687,681 Oct 29, 2026 ET · Open $0.86 · High $0.87 · Low $0.73 · Close $0.76 · Volume 1,128,701 Oct 30, 2026 ET · Open $0.71 · High $0.79 · Low $0.65 · Close $0.77 · Volume 787,865 Nov 2, 2026 ET · Open $0.77 · High $0.90 · Low $0.74 · Close $0.84 · Volume 523,073 Nov 3, 2026 ET · Open $0.79 · High $0.95 · Low $0.78 · Close $0.88 · Volume 342,368 Nov 4, 2026 ET · Open $0.86 · High $0.86 · Low $0.80 · Close $0.82 · Volume 136,781 Nov 5, 2026 ET · Open $0.80 · High $0.81 · Low $0.71 · Close $0.73 · Volume 184,917 Nov 6, 2026 ET · Open $0.75 · High $0.78 · Low $0.72 · Close $0.73 · Volume 109,261 Nov 9, 2026 ET · Open $0.72 · High $0.72 · Low $0.64 · Close $0.64 · Volume 190,594 Nov 10, 2026 ET · Open $0.67 · High $0.69 · Low $0.60 · Close $0.60 · Volume 193,739 Nov 11, 2026 ET · Open $0.60 · High $0.62 · Low $0.59 · Close $0.59 · Volume 71,016 Nov 12, 2026 ET · Open $0.57 · High $0.70 · Low $0.56 · Close $0.67 · Volume 221,391 Nov 13, 2026 ET · Open $0.66 · High $0.67 · Low $0.61 · Close $0.61 · Volume 80,471 Nov 16, 2026 ET · Open $0.60 · High $0.65 · Low $0.56 · Close $0.63 · Volume 162,304 Nov 17, 2026 ET · Open $0.63 · High $0.63 · Low $0.58 · Close $0.61 · Volume 31,714 Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of Nov 17, 2026, 8:42 PM ET
Initial 6M price range summary Range 6M First close $1.90 Last close $0.61 High $3.30 Low $0.52 Volume 965,750,794
Open $0.63 Historical · Nov 17, 2026
Previous close $0.63 Nov 16, 2026 close
Day range $0.58 – $0.63 Historical · Nov 17, 2026
52-week range $0.07 – $1.53 Through Nov 17, 2026
Volume 31.71K Historical · Nov 17, 2026
Average volume (30 calendar days, 17 sessions) 9.33M Through Nov 17, 2026
Market cap —
P/E (TTM) 6.6
Forward P/E —
EPS (TTM) −$2.80
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) —
Price history AZTR · amex · USD
Last completed session: Nov 17, 2026
Split-adjusted · volume in shares
November 2026 · 12 completed sessions Date Open High Low Close Change Volume Nov 17 0.627 0.627 0.584 0.608 −0.019−3.030303% 31,714 Open 0.627 High 0.627 Low 0.584 Nov 16 0.5969 0.6524 0.56 0.627 +0.0186+3.057199% 162,304 Open 0.5969 High 0.6524 Low 0.56 Nov 13 0.66 0.67 0.6084 0.6084 −0.0601−8.990277% 80,471 Open 0.66 High 0.67 Low 0.6084 Nov 12 0.5662 0.7004 0.5613 0.6685 +0.0833+14.23445% 221,391 Open 0.5662 High 0.7004 Low 0.5613 Nov 11 0.60 0.6188 0.5852 0.5852 −0.0148−2.466667% 71,016 Open 0.60 High 0.6188 Low 0.5852 Nov 10 0.665 0.6895 0.60 0.60 −0.044−6.832298% 193,739 Open 0.665 High 0.6895 Low 0.60 Nov 9 0.7241 0.7241 0.644 0.644 −0.0885−12.081911% 190,594 Open 0.7241 High 0.7241 Low 0.644 Nov 6 0.749 0.7799 0.7177 0.7325 +0.0074+1.020549% 109,261 Open 0.749 High 0.7799 Low 0.7177 Nov 5 0.80 0.811 0.71 0.7251 −0.0906−11.107025% 184,917 Open 0.80 High 0.811 Low 0.71 Nov 4 0.8569 0.8571 0.7952 0.8157 −0.0681−7.705363% 136,781 Open 0.8569 High 0.8571 Low 0.7952 Nov 3 0.7921 0.9496 0.78 0.8838 +0.0475+5.67978% 342,368 Open 0.7921 High 0.9496 Low 0.78 Nov 2 0.7686 0.90 0.7404 0.8363 +0.0671+8.723349% 523,073 Open 0.7686 High 0.90 Low 0.7404
Notable price movement Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.
Nov 12
$0.67 +14.23%
Trading volume was 0.0 times the 30-day average, with 221.39K shares traded.
Nov 9
$0.64 −12.08%
Trading volume was 0.0 times the 30-day average, with 190.59K shares traded.
Nov 5
$0.73 −11.11%
Trading volume was 0.0 times the 30-day average, with 184.92K shares traded.
Options flow — · Options flow not available
Q Score — /100 —
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Not scored: Equity peers
Liquidity Not scored Short Not scored Squeeze Not scored Trend Not scored Momentum Not scored Valuation Not scored Stability Not scored What each one means Liquidity Not scored
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short Not scored
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend Not scored
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum Not scored
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation Not scored
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability Not scored
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → How AZTR compares with its industry Against 592 other US-listed Biotechnology stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Strongest pointsThree-month return was 350.4%, higher than 99% of 559 peers.Peer median −31.7% · As of Nov 16, 2026 Points of cautionLatest-quarter year-over-year sales growth was -100%, with only 0% of 592 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026 One-month return was -53.9%, with only 5% of 567 peers reporting a lower value.Peer median −10.3% · As of Nov 16, 2026 Trailing-year return on equity was -256.7%, with only 15% of 554 peers reporting a lower value.Peer median −67.8% · As of Nov 17, 2026 Valuation Mixed valuation signals
Metric AZTR Peer median
Profitability Profitability metrics are lower than most peers.
Metric AZTR Peer median
Growth Growth metrics are lower than most peers.
Metric AZTR Peer median
Quarterly sales growth, year over year −100.0% 0.0%
Lowest of 592 peers Higher than 0% of 592 peers
5-year sales growth rate — 11.3%
Not ranked: only 140 of 592 peers report it
Balance sheet Balance sheet metrics are lower than most peers.
Metric AZTR Peer median
Momentum Returns are higher than most peers.
Metric AZTR Peer median
1-year return +29.2% −29.8%
Higher than 79% of 522 peers
6-month return +155.8% −24.0%
Top 10% of peers Higher than 97% of 547 peers
3-month return +350.4% −31.7%
Top 10% of peers Higher than 99% of 559 peers
How to read this The dot marks where AZTR ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026
Upcoming events — · Upcoming events not available
Analyst consensus No Coverage
0 Strong Buy
0 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 0 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $6.50
Average $6.50
High $6.50
As of Nov 18, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −4.00 −3.00 −2.00 −1.00 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.25 −$0.29 —
Q2 2026 −$0.21 −$0.17 —
Q1 2026 −$0.04 −$0.25 —
Annual 2025 — −$2.25 —
Q3 2025 — −$0.67 —
Q2 2025 — −$0.18 —
Q1 2025 — −$0.23 —
Annual 2024 −$3.33 −$2.37 —
Smart-money activity In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
Mar 29, 2024 Insider buy Staskey Norm Buy $10.0K Form 4 Feb 13, 2024 Insider buy Whitfill Travis Buy $4.5K Form 4 Feb 13, 2024 Insider buy Staskey Norm Buy $990 Form 4 Feb 13, 2024 Insider buy Salva Francisco D. Buy $100.0K Form 4 Jun 21, 2023 Insider buy Kreis Leslie W. / Cavu Advisors, LLC / Cavu Management, LP / BIOS Fund I, LP / BIOS Fund I QP, LP / Bios Equity Partners, LP / BIOS Fund II, LP / BIOS Fund II NT, LP / BIOS Fund II QP, LP / Bios Equity Partners II, LP Buy $368.5K Form 4 Jun 21, 2023 Insider buy Kreis Leslie W. / Cavu Advisors, LLC / Cavu Management, LP / BIOS Fund I, LP / BIOS Fund I QP, LP / Bios Equity Partners, LP / BIOS Fund II, LP / BIOS Fund II NT, LP / BIOS Fund II QP, LP / Bios Equity Partners II, LP Buy Unavailable Form 4 Jun 21, 2023 Insider sell Kreis Leslie W. / Cavu Advisors, LLC / Cavu Management, LP / BIOS Fund I, LP / BIOS Fund I QP, LP / Bios Equity Partners, LP / BIOS Fund II, LP / BIOS Fund II NT, LP / BIOS Fund II QP, LP / Bios Equity Partners II, LP Sell Unavailable Form 4 Jun 21, 2023 Insider buy Kreis Leslie W. / Cavu Advisors, LLC / Cavu Management, LP / BIOS Fund I, LP / BIOS Fund I QP, LP / Bios Equity Partners, LP / BIOS Fund II, LP / BIOS Fund II NT, LP / BIOS Fund II QP, LP / Bios Equity Partners II, LP Buy $2.3M Form 4 All smart-money activity →
News and press releases News and press releases are not available.
All AZTR news → Company profile Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically
CEO Mr. Francisco D. Salva
Headquarters Branford, CT, United States
Employees 13
IPO date Jun 16, 2023
Sector Healthcare
Industry Biotechnology Q Score — /100 —
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Not scored: Equity peers
Liquidity Not scored Short Not scored Squeeze Not scored Trend Not scored Momentum Not scored Valuation Not scored Stability Not scored What each one means Liquidity Not scored
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short Not scored
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend Not scored
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum Not scored
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation Not scored
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability Not scored
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → Upcoming events — · Upcoming events not available
Analyst consensus No Coverage
0 Strong Buy
0 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 0 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $6.50
Average $6.50
High $6.50
As of Nov 18, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −4.00 −3.00 −2.00 −1.00 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.25 −$0.29 —
Q2 2026 −$0.21 −$0.17 —
Q1 2026 −$0.04 −$0.25 —
Annual 2025 — −$2.25 —
Q3 2025 — −$0.67 —
Q2 2025 — −$0.18 —
Q1 2025 — −$0.23 —
Annual 2024 −$3.33 −$2.37 —
Company profile Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically
CEO Mr. Francisco D. Salva
Headquarters Branford, CT, United States
Employees 13
IPO date Jun 16, 2023
Sector Healthcare
Industry Biotechnology